文献速递神经康复

机器人辅助步态训练对卒中患者功能性步行能力的真实世界回顾性分析

Robot-assisted gait training on functional ambulation in patients with stroke: a retrospective real-world analysis across five robotic devices.
PubMed 文献 · J Neuroeng Rehabil · 2026-05-18

本研究回顾性纳入2015至2022年单中心2947例住院康复卒中患者,比较机器人辅助步态训练(RAGT)与常规治疗对功能性步行分类改善(效应器)的影响。RAGT组基线功能更差但效应器比例相似(58.0% vs 62.5%),整体RAGT与效应器结局无关;Morning Walk和Exowalk与更高效应器几率相关,Erigo与更低几率相关。

要点

  • RAGT整体未优于常规治疗,但不同设备效果差异显著。
  • Morning Walk和Exowalk与更高效应器几率独立相关。
  • Erigo与更低效应器几率相关,设备选择需个体化。

核心结论

  • RAGT整体不优于常规治疗,但特定设备与步行功能改善相关,强调个体化机器人干预的重要性。

研究设计与样本

  • 单中心回顾性队列研究,纳入2015至2022年住院康复的2947例卒中患者,分为RAGT组和常规治疗组。
  • 采用多变量logistic回归和分类回归树(CART)模型识别效应器预测因素并探索设备选择决策。

主要发现

  • RAGT组基线功能更差,但效应器比例与对照组相似(58.0% vs 62.5%)。
  • 整体RAGT与效应器结局无显著关联。
  • 与对照组相比,Morning Walk(aOR=3.25;95%CI:1.79-5.87)和Exowalk(aOR=4.42;95%CI:1.84-10.64)与更高效应器几率显著相关。
  • Erigo与更低效应器几率相关(aOR=0.58;95%CI:0.35-0.96)。
  • CART模型识别Berg平衡量表、简易精神状态检查和Fugl-Meyer评估为效应器状态的关键预测因素。

关键数值与推荐

  • 功能改善定义为功能性步行分类(FAC)增益≥1分。
  • 效应器比例:RAGT组58.0%,对照组62.5%。
  • Morning Walk的aOR=3.25(95%CI:1.79-5.87),Exowalk的aOR=4.42(95%CI:1.84-10.64),Erigo的aOR=0.58(95%CI:0.35-0.96)。

临床怎么用

  • 卒中住院康复中,RAGT整体可不作为常规治疗的优先替代,但可依据设备类型选择。
  • 对适合患者,可考虑选用Morning Walk或Exowalk以改善步行功能。
  • Erigo可能与较低步行功能改善几率相关,选用时需谨慎评估。
  • 可利用Berg平衡量表、简易精神状态检查和Fugl-Meyer评估等临床特征辅助预测效应器状态和设备分配。

局限性

  • 单中心回顾性设计,可能存在选择偏倚和混杂因素。
  • 研究结果基于真实世界数据,设备间比较非随机化,因果推断受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robot-assisted gait training (RAGT) is increasingly used in stroke rehabilitation. However, its comparative effectiveness across device types remains unclear. This study explored the effectiveness of RAGT compared to conventional treatment using real-world clinical data. METHODS: This retrospective cohort study included 2,947 patients with stroke who received inpatient rehabilitation at a single center between 2015 and 2022. Patients were divided into RAGT and conventional treatment groups. Functional improvement was defined as a gain of ≥ 1 point in the Functional Ambulation Category. Multivariable logistic regression and classification and regression tree (CART) models were applied to identify predictors of favorable outcomes (effectors) and to explore clinical decision-making for device selection. RESULTS: The RAGT group showed poorer baseline function but had a similar proportion of effectors (58.0%) compared to the control group (62.5%). Overall, RAGT was not associated with effector outcome versus control. Among RAGT devices, Morning Walk (adjusted odds ratio [aOR] = 3.25; 95% confidence interval [CI]: 1.79-5.87) and Exowalk (aOR = 4.42; 95% CI: 1.84-10.64) were significantly associated with higher odds of effector status compared to control, whereas Erigo was associated with lower odds (aOR = 0.58; 95% CI: 0.35-0.96). CART models identified clinical features, such as the Berg Balance Scale, the Mini-Mental Status Examination, and the Fugl-Meyer Assessment, as key predictors of effector status and revealed patterns in robotic device allocation. CONCLUSION: While RAGT was not superior to conventional treatment, certain devices were associated with improved gait function. These findings highlight the importance of tailoring robotic interventions.

来源:J Neuroeng Rehabil,查看原文。版权归原作者所有。

引用

  1. Park D, Koo D, Park GM, et al. Robot-assisted gait training on functional ambulation in patients with stroke: a retrospective real-world analysis across five robotic devices. J Neuroeng Rehabil. 2026. PMID: 42151953. doi:10.1186/s12984-026-02010-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。